Novartis (Belgium)

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1007/s00253-003-1354-z Exudate gums: occurrence, production, and applications
https://doi.org/10.1182/blood-2008-12-196543 Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study
https://doi.org/10.1016/s0924-2244(02)00131-0 Resistant starch and “the butyrate revolution”
https://doi.org/10.1111/j.1467-789x.2006.00222.x Low‐carbohydrate diets: nutritional and physiological aspects
https://doi.org/10.1016/j.rmed.2009.06.014 “Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
https://doi.org/10.1530/eje-07-0358 AcroBel – the Belgian registry on acromegaly: a survey of the ‘real-life’ outcome in 418 acromegalic subjects
https://doi.org/10.1002/1521-379x(200204)54:3/4<89::aid-star89>3.0.co;2-i Renewable Raw Materials in Europe ??-?? Industrial Utilisation of Starch and Sugar [1]
https://doi.org/10.1016/j.ejca.2007.10.003 The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: Results of a phase I study with pharmacokinetics
https://doi.org/10.1007/s10741-020-09979-z Clinical inertia in the treatment of heart failure: a major issue to tackle
https://doi.org/10.2147/opth.s49385 Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study
https://doi.org/10.1016/j.leukres.2014.02.003 Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes
https://doi.org/10.1016/s0378-5173(99)00274-4 The use of modulated temperature differential scanning calorimetry for the characterisation of food systems
https://doi.org/10.1351/pac200274071281 Erythritol. Functionality in noncaloric functional beverages
https://doi.org/10.2147/opth.s281501 <p>Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)</p>
https://doi.org/10.1371/journal.pone.0244485 Diagnosis, treatment, and follow-up of heart failure patients by general practitioners: A Delphi consensus statement
https://doi.org/10.1016/j.jval.2021.11.1196 POSC371 Qualitative Research Exploring the Patient Experience of Symptoms and Health-Related Quality of Life Impacts in Chronic Ocular Surface Pain
https://doi.org/10.1111/ejh.13022 Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific survey
https://doi.org/10.1016/j.leukres.2021.106734 No margin for non-adherence: Probabilistic kaplan-meier modeling of imatinib non-adherence and treatment response in CML (ADAGIO study)
https://doi.org/10.1179/2295333714y.0000000097 Myelofibrosis patients in Belgium: disease characteristics
https://doi.org/10.1016/j.semarthrit.2023.152264 Burden of adult-onset Still's disease: A systematic review of health-related quality of life, utilities, costs and resource use
https://doi.org/10.1155/2017/9842450 Hierarchical Modeling of Patient and Physician Determinants of Blood Pressure Outcomes in Hypertensive Patients with and without Diabetes: Pooled Analysis of Six Observational Valsartan Studies with 15,282 Evaluable Patients
https://doi.org/10.1186/s41927-025-00515-w Canakinumab treatment patterns in sJIA, FMF, TRAPS, and MKD/HIDS: real-world insights from a Belgian non-interventional study
https://doi.org/10.1016/s0303-8467(00)00093-7 Successful immunoglobulin treatment in a patient with neuromyotonia
https://doi.org/10.1111/jdv.15684 A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real‐world study in Belgium
https://doi.org/10.1186/s13223-019-0331-8 Variability in total serum IgE over 1 year in severe asthmatics
https://doi.org/10.1007/s00223-013-9812-9 Remission Over 3 Years in Patients with Paget Disease of Bone Treated with a Single Intravenous Infusion of 5 mg Zoledronic Acid
https://doi.org/10.1111/j.1742-1241.2010.02562.x Antihypertensive effectiveness of aliskiren for the ‘real-world’ management of hypertension: multilevel modelling of 180-day blood pressure outcomes (the Belgian DRIVER Study)
https://doi.org/10.2196/47245 Patient Experiences and Insights on Chronic Ocular Pain: Social Media Listening Study
https://doi.org/10.1097/01.tp.0000076473.71399.26 Cyclosporine pharmacokinetics and dose monitoring after lung transplantation: comparison between cystic fibrosis and other conditions
https://doi.org/10.1007/s00520-013-1934-0 Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors
https://doi.org/10.1345/aph.1p663 Effectiveness of Amlodipine-Valsartan Single-Pill Combinations: Hierarchical Modeling of Blood Pressure and Total Cardiovascular Disease Risk Outcomes (the EXCELLENT Study)
https://doi.org/10.1007/s00277-011-1164-9 Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes
https://doi.org/10.2147/copd.s125564 Inhaled treatment of COPD: a Delphi consensus statement
https://doi.org/10.1007/s13300-019-0601-y Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in “Real-World” Management of Type 2 Diabetes Mellitus: The G-FORCE Study
https://doi.org/10.3389/fmed.2020.00036 Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey
https://doi.org/10.1159/000499329 Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium
https://doi.org/10.2147/opth.s242547 <p>Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUSTM Study</p>
https://doi.org/10.1111/all.15785 Epidemiology of sensitization to perennial aeroallergens in adults with severe asthma in Belgium. The BEIgE study
https://doi.org/10.3389/fmed.2023.1257413 Care pathway analysis and evidence gaps in adult-onset Still’s disease: interviews with experts from the UK, France, Italy, and Germany
https://doi.org/10.1111/jch.12163 Hierarchical Modeling of Patient and Physician Determinants of Blood Pressure Outcomes in Adherent vs Nonadherent Hypertensive Patients: Pooled Analysis of 6 Studies With 14,646 Evaluable Patients
https://doi.org/10.1016/j.cnur.2005.10.002 Longitudinal Observational Studies to Study the Efficacy-Effectiveness Gap in Drug Therapy: Application to Mild and Moderate Dementia
https://doi.org/10.3399/bjgp15x683101 Predicting blood pressure outcomes using single-item physician-administered measures: a retrospective pooled analysis of observational studies in Belgium
https://doi.org/10.1016/j.pcd.2016.05.008 Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study)
https://doi.org/10.5021/ad.2013.25.1.28 Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study)
https://doi.org/10.1200/jco.2009.27.15_suppl.9630 Zoledronic acid (ZOL) treatment (Rx) of ≥2 years in patients (pts) with metastatic bone disease (MBD) or multiple myeloma (MM): Six-month results from the LOTUZ study
https://doi.org/10.1182/blood.v110.11.5163.5163 Multimethod Clinical Assessment of Patterns and Prevalence of Nonadherence (NA) to Imatinib Treatment (IMRx) in Patients (Pts) with Chronic Myeloid Leukemia (CML): Results from the ADAGIO Study.
https://doi.org/10.1182/blood.v110.11.5164.5164 Canonical Correlation Analysis (CCA) of Imatinib Treatment (ImRx) Nonadherence (NA) with Associated Patient Variables (APVs) in Chronic Myeloid Leukemia (CML) - Results from the ADAGIO Study.
https://doi.org/10.1038/s41598-024-64243-w Real-life effectiveness of sacubitril/valsartan in older Belgians with heart failure, reduced ejection fraction and most severe symptoms
https://doi.org/10.1002/clc.24330 Characteristics of Patients With Atherosclerotic Cardiovascular Disease in Belgium and Current Treatment Patterns for the Management of Elevated LDL‐C Levels
https://doi.org/10.1080/03007995.2021.1877124 Gender-stratified hierarchical modeling of patient and physician determinants of antihypertensive treatment outcomes: pooled analysis of seven prospective real-world studies with 17,044 patients
https://doi.org/10.1016/j.jval.2021.11.032 P33 Patient Experiences and Insights on Chronic Ocular Pain from a Social Media Listening Study
https://doi.org/10.1016/j.jval.2020.08.1985 PSS23 Burden of Dry Eye Disease and Treatment Experience with Lifitegrast: A CROSS-Sectional Patient Survey in US and Canada
https://doi.org/10.1016/j.jval.2012.08.2055 PSS8 Non-Interventional Study on the Burden of Illness in Diabetic Macular Edema (DME) in Belgium
https://doi.org/10.1016/j.jval.2019.09.1753 PMU135 PATIENT-REPORTED OUTCOME MEASURES IN PATIENTS WITH CHRONIC OCULAR SURFACE PAIN : A LITERATURE REVIEW
https://doi.org/10.1016/j.jaip.2024.08.016 The Belgian IgE study: Staphylococcus aureus toxins in adult severe asthma
https://doi.org/10.1080/01971520009349500 Direct Micro-Radioimmunoassay of the New Renin Inhibitor Cgp 60536
https://doi.org/10.1345/aph.1l576 Effectiveness of Valsartan for Treatment of Hypertension: Patient Profiling and Hierarchical Modeling of Determinants and Outcomes (the Preview Study)
https://doi.org/10.1185/030079907x226375 Patient and caregiver outcomes after 6 ± 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease:the Belgian FExT study
https://doi.org/10.1159/000136654 Belgian Observational Drug Utilization Study of Pimecrolimus Cream 1% in Routine Daily Practice in Atopic Dermatitis
https://doi.org/10.1038/jhh.2010.71 Gender-specific, multi-level determinants of outcomes of antihypertensive treatment: a sub-analysis of the Belgian PREVIEW study
https://doi.org/10.1016/j.archger.2009.07.009 Hierarchical linear and logistic modeling of outcomes of antihypertensive treatment in elderly patients: Findings from the PREVIEW study
https://doi.org/10.1016/j.dsx.2010.07.012 The elusive type 2 diabetes individual achieving tight blood pressure target: A phenotypic study
https://doi.org/10.1179/2295333714y.0000000018 Effectiveness and tolerability of second-line therapy with vildagliptin versus other oral agents in type 2 diabetes (EDGE):post-hocsubanalysis of the Belgian data
https://doi.org/10.1111/ijlh.12556 A novel approach for BCRABL1 standardization to improve International Scale estimation
https://doi.org/10.1182/blood.v112.11.2379.2379 Patient Nonadherence and Treatment Response to Imatinib in Patients with Chronic Myeloid Leukemia: Results from the ADAGIO Study
'Real-life' persistence beyond the first year of omalizumab treatment in patients with severe allergic asthma: The R-Pixel study
https://doi.org/10.1016/j.numecd.2011.06.005 Patient- and physician-level determinants of blood pressure response to treatment in normal weight and overweight patients (the PREVIEW study)
https://doi.org/10.1182/blood.v110.11.5165.5165 Promoting Patient (pt) Adherence (PA) with Imatinib Treatment (IMRx) in Chronic Myeloid Leukemia (CML): Physicians (MD) Perceptions of Utility (Effectiveness [FX], Feasibility [FB], Cost [CO]) and Rankings of Clinical Applicability (CAPL) of 13 Adherence-Enhancing Strategies (AESs) - Results from the ADAGIO Study.
The European Commission adopts a package of measures to facilitate competition law private actions in the EU
https://doi.org/10.1002/9783527614899.ch16 Bleach activators
https://doi.org/10.1016/s1053-2498(01)00523-x Comparison of cyclosporin pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and for other conditions
https://doi.org/10.1200/jco.2005.23.16_suppl.3594 A phase IB, open-label, parallel design study of PTK787/ZK 222584 in combination with irinotecan in patients (Pts) with metastatic colorectal cancer (CRC) to investigate the interaction between the agents
New therapeutic possibilities handling residual azoospermia.
https://doi.org/10.1016/j.jval.2011.02.316 PSS14 COST-UTILITY ANALYSIS OF RANIBIZUMAB (LUCENTIS®) IN WET-AMD BASED ON REAL-LIFE DATA COLLECTED IN THE HELIOS STUDY AFTER RANIBIZUMAB REIMBURSEMENT IN BELGIUM
https://doi.org/10.1016/j.acvd.2012.11.006 Modelling of blood pressure outcomes in patients with and without established cardiovascular or renal disease following treatment with valsartan (the PREVIEW study)
https://doi.org/10.1016/j.jval.2013.08.1318 Two Simple Methods of Measuring Adherence in Hypertensive Patients Are Predictive of Blood Pressure Control: Pooled Analysis of 17,516 Patients from Seven Valsartan Studies
https://doi.org/10.1080/03746606309467914 I.—On the Nature of the Perigynium or Utriculus of the Genus Carex
https://doi.org/10.1016/j.jval.2015.09.096 Association of Adherence Status As Measured Using Two Single-Item Physician-Administered Methods With Cardiovascular Risk In Patients Taking Antihypertensive Medication
Media and Antitrust: An overview of EU and national case law
Mergers and joint ventures: An overview of EU and national case law
The EU General Court upholds fine imposed on energy corporation for failing to notify a transaction highlighting the importance of compliance with EU merger control filing requirements (Electrabel)
https://doi.org/10.1016/j.leukres.2018.01.018 Identification of chronic myeloid leukemia patients treated with imatinib who are potentially eligible for treatment discontinuation by assessing real-life molecular responses on the international scale in a EUTOS-certified lab
https://doi.org/10.1080/00015385.2020.1765105 The in- and out-of-hospital management of HF patients: results from a nationwide Belgian survey
https://doi.org/10.1183/13993003.congress-2020.1098 Allergy Testing in Asthmatics and Severe Asthmatics in Belgium : Role of Comorbidities
https://doi.org/10.1183/13993003.congress-2020.242 Allergy testing in asthmatics and severe asthmatics: habits among respiratory physicians in Belgium
https://doi.org/10.1080/03007995.2020.1853082 Hierarchical modeling of blood pressure determinants and outcomes following valsartan treatment in hypertensive patients with known comorbidities: pooled analysis of six prospective real-world studies including 11,999 patients
https://doi.org/10.1016/j.jval.2020.08.1964 PSS2 Patient-Reported Burden of Dry Eye Disease in Germany: Results of an Online CROSS-Sectional Survey
https://doi.org/10.1016/j.jval.2020.08.1975 PSS13 Risk Factors for Chronic Ocular PAIN: Evidence from a Literature Review
https://doi.org/10.1016/j.jval.2020.08.691 PDG8 A Chart Review Study of Dry Eye Disease Symptoms and Treatment Patterns Among Patients Receiving Lifitegrast in the United States and Canada
https://doi.org/10.1158/1538-7445.sabcs20-ps9-06 Abstract PS9-06: Adherence to and patient satisfaction with the combination therapy of exemestane and everolimus in postmenopausal women with HR+ HER2- advanced breast cancer: Results from the IPSOC-mamma study
https://doi.org/10.1200/jco.2021.39.15_suppl.7038 Novel application of Kaplan-Meier methods to model tolerance for nonadherence to imatinib in patients with chronic myeloid leukemia (CML) in the ADAGIO study.
https://doi.org/10.1016/j.jval.2021.11.441 POSB430 Elicitation of Health State Utilities Associated with Varying Severities of Dry Eye Disease
https://doi.org/10.1136/annrheumdis-2022-eular.594 AB0754 REAL WORLD EVIDENCE ON DISEASE ACTIVITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH TUMOUR NECROSIS FACTOR INHIBITORS AND/OR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN ROUTINE CARE: RESULTS FROM THE “INVISIBLE” STUDY
https://doi.org/10.1016/j.jval.2022.09.2024 PCR89 Qualitative Research to Understand the Lived Experience of Patients with Dry Eye Disease (DED), Meibomian Gland Dysfunction (MGD), and Sjogren's Syndrome Dry Eye Disease (SS-DED)
https://doi.org/10.1016/j.jval.2022.09.1960 PCR25 Content Validity Assessment of a Newly-Developed Patient-Reported Outcome Measure for Dry Eye Disease (DED), Meibomian Gland Dysfunction (MGD), and Sjogren's Syndrome Dry Eye Disease (SS-DED)
https://doi.org/10.1183/13993003.congress-2022.2301 The epidemiology of sensitization to perennial aeroallergens in adult patients with severe asthma in Belgium. The Belgian IgE (BEIgE) study
https://doi.org/10.1183/13993003.congress-2023.pa1943 Sensitization to Staphylococcus aureus toxins in Severe Asthma. The Belgian IgE (BEIgE) study.
https://doi.org/10.1136/annrheumdis-2024-eular.1304 AB0028 LONG-TERM TREATMENT PATTERNS OF CANAKINUMAB IN MONOGENIC AUTOINFLAMMATORY DISEASES (FMF, TRAPS, HIDS/MKD) AND SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) – 5-YEARS DATA FROM A BELGIAN REGISTRY
https://doi.org/10.1016/j.atherosclerosis.2025.119586 Real-world adherence, LDL-C lowering effect and goal-attainment of inclisiran in Belgian patients with atherosclerotic cardiovascular disease: The BE.REAL registry
https://doi.org/10.1002/iju5.70113 Cellular Angiofibroma of the Prostate